US Edition
News from Lupin
We’ve assigned a rating of Unknown factuality to Lupin. You can read more about how we’ve determined Lupin’s credibility and reliability as a news source here: https://ground.news/rating-system.
Media Bias Ratings
Do you disagree?
Edit bias
Learn more about Media Bias Ratings.
Factuality
Learn more about Factuality Ratings
Reveal Factuality Ratings by upgrading to a Premium account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Ownership
Learn more about Ownership categories
Reveal Ownership Data by upgrading to a Vantage account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Top Lupin News
Cancer · United StatesLupin secures USFDA approval for Armlupeg, a biosimilar indicated for treating neutropenia in cancer patients. The drug, produced at Lupin’s Pune facility, offers a cost-effective alternative to Neulasta. Lupin aims to expand its biosimilar portfolio, enhancing healthcare accessibility in the US market.See the Story
Lupin Gains USFDA Approval for New Cancer Biosimilar
50% Right coverage: 4 sources
Finance · MumbaiHere goes the top 10 most powerful women in business for 2025. Women are standing up at the helm of defining the finance and business of the world. There is no longer an outsider but an active participant. From finance to technology and merchandising to manufacturing, these women lead markets and policies and shape innovation agendas. Power doesn’t lie in titles but in the ability to lead through disruption and foster change while redefining gl…See the Story
Top 10 Most Powerful Women in Business in 2025
Mumbai · MumbaiLupin Manufacturing Solutions (LMS), a subsidiary of Lupin, announced a long-term strategic alliance with PolyPeptide Group AG, a global contract development and manufacturing organisation (CDMO) specialising in peptide-based active pharmaceutical ingredients. The collaboration aims to enhance supply chain resilience, improve operational efficiency, and accelerate readiness for growth in the global peptides market. It also focuses on advancing n…See the Story
